QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-buy-on-xp-lowers-price-target-to-23

UBS analyst Thiago Batista maintains XP (NASDAQ:XP) with a Buy and lowers the price target from $24 to $23.

 price-over-earnings-overview-xp
Price Over Earnings Overview: XP
10/07/2025 21:01:14

 citigroup-maintains-buy-on-xp-raises-price-target-to-23

Citigroup analyst Gustavo Schroden maintains XP (NASDAQ:XP) with a Buy and raises the price target from $22 to $23.

 stock-market-today-nasdaq-100-futures-slip-palo-alto-xp-allarity-earnings-in-focus-updated

U.S. stock futures slipped on Monday following Friday's mixed moves. Futures of major benchmark indices were lower.

 xps-earnings-a-preview
XP's Earnings: A Preview
08/15/2025 14:01:17

 ubs-maintains-buy-on-xp-raises-price-target-to-24

UBS analyst Thiago Batista maintains XP (NASDAQ:XP) with a Buy and raises the price target from $17 to $24.

 goldman-sachs-upgrades-xp-to-buy-raises-price-target-to-23

Goldman Sachs analyst Tito Labarta upgrades XP (NASDAQ:XP) from Neutral to Buy and raises the price target from $17 to $23.

 goldman-sachs-maintains-neutral-on-xp-raises-price-target-to-17

Goldman Sachs analyst Tito Labarta maintains XP (NASDAQ:XP) with a Neutral and raises the price target from $15 to $17.

 b-of-a-securities-maintains-neutral-on-xp-raises-price-target-to-19

B of A Securities analyst Mario Pierry maintains XP (NASDAQ:XP) with a Neutral and raises the price target from $16 to $19.

 xp-q1-eps-039-beats-038-estimate-sales-74193m-miss-75503m-estimate

XP (NASDAQ:XP) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.38 by 2.63 percen...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION